DNX-2401 plus Pembrolizumab Is Safe in Recurrent Glioblastoma

Article navigation

Research Watch| August 04 2023

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2023

American Association for Cancer Research

Cancer Discov (2023) 13 (8): OF6.

https://doi.org/10.1158/2159-8290.CD-RW2023-083

Abstract

Pembrolizumab plus the oncolytic virus DNX-2401 is safe and efficacious in a subset of patients with glioblastoma.

2023

American Association for Cancer Research

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.